Applicant, as named in the Orange Book
Long Grove Pharms
Next listed expiry: Norepinephrine Bitartrate In 0.9% Sodium Chloride on 30 Jan 2038. 1 products with live protection, 2 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Norepinephrine Bitartrate In 0.9% Sodium Chloride NDA 214628 · 3 strengths norepinephrine bitartrate | 30 Jan 2038 patent |
Recent events
- Ak-Fluor 10% · Generic approved · ANDA 220046, Bpi LabsApproved 30 Apr 2026Detected 25 Oct 2026
- Ak-Fluor 10% · Generic approved · ANDA 218651, Zydus LifesciencesApproved 1 Jun 2026Detected 25 Oct 2026
Products without listed protection (2)
| Drug | Earliest generic entry |
|---|---|
| Ak-Fluor 10% NDA 022186 fluorescein sodium | open now no listed protection |
| Vasopressin In Sodium Chloride 0.9% NDA 217766 · 2 strengths vasopressin | open now no listed protection |